View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brentuximab Vedotin 1.8 / Nivolumab 3, Hodgkin Lymphoma, cycle 2-4
Protocol-ID: 1904 V1.0 (Mini), BRNT1.8/NIVO3, Hodgkin, C2-4Indication(s)
- Hodgkin Lymphoma; ICD-10 C81.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 17.12.2021